Search Results

Stanford Cancer Institute Michael Longaker, MD, is the senior author on a study finding that scar tissue that forms around a growing pancreatic ductal adenocarcinoma can indicate how long a patient is likely to live. Read More

Legorreta Cancer Center at Brown University The Worldwide Innovative Network (WIN) Consortium in precision cancer medicine and Brown University have announced the election of Wafik El-Deiry, MD, PhD, FACP, director of the Legorreta Cancer Center at Brown University, as chair of the WIN Consortium. Read More

For over 50 years, Edith P. Mitchell, MD, MACP, FCPP, FRCP (London), has blazed trails in diverse fields, from being the first female physician to achieve the rank of Brigadier General in the United States Air Force to leading diversity programs and serving as enterprise vice president for cancer disparities at Sidney Kimmel Cancer Center at Jefferson Health. Dr. Mitchell will deliver the opening keynote at 8:00 am central time on Monday, March 12, during the 2024 AACI Leadership Diversity and …

Legorreta Cancer Center at Brown University The Legorreta Cancer Center at Brown University, the American Cancer Society (ACS), and Morehouse School of Medicine have joined to support an extended cancer research internship experience at Brown. The summer program originated via an ACS-Fostering Innovation Award granted to Wafik S. El-Deiry, MD, PhD, FACP, director of the cancer center. Read More

Wilmot Cancer Institute, UR Medicine Researchers have made a breakthrough by learning about the genetic changes that occur during tumor migration – and have also found a drug that can obstruct the process. The next step is a groundbreaking clinical trial, planned for early in 2024, to test the drug on pancreatic cancer that has spread to the liver. Read More

Fox Chase Cancer Center, Temple Health Robert Uzzo, MD, MBA, FACS, president and CEO of Fox Chase Cancer Center, was recently recognized with the Society of Urologic Oncology’s Joseph A. Smith Jr. Mentorship Award. Read More

UCLA Jonsson Comprehensive Cancer Center Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have received two grants totaling $9.1 million from the National Cancer Institute to advance liquid biopsy technologies for the early detection of cancer. Read More

Roswell Park Comprehensive Cancer Center (RPCCC), America's first cancer center and New York State’s only NCI-designated Comprehensive Cancer Center outside of the New York City Metropolitan area, is recruiting for the Chair of the Department of Surgical Oncology. The department is comprised of 17 surgeons representing all aspects of surgical oncology; upper GI, HPB, colorectal, melanoma, sarcoma, endocrine, breast, and regional therapies such as HIPEC. Roswell Park is on the cutting edge of ro…

The Dartmouth Cancer Center (DCC) is one of only 53 NCI-Designated Comprehensive Cancer Centers and the only one north of Boston and east of Buffalo. DCC is committed to providing access to research-based, high-quality care, advanced technologies, and clinical trials for patients throughout northern New England. Its research, clinical care, and training are integrated at the Cancer Center with a priority on translation of innovation, interdisciplinary care, team science, and career development.…

Duke Cancer Institute, Duke University Medical Center Duke University School of Medicine and The University of Texas MD Anderson Cancer Center have developed a new strategy to protect bones during cancer treatment using a unique drug delivery system with tiny carriers. Researchers shielded bone-forming cells in mice after radiation by targeting a specific protein with a recently approved medication. Read More

The Tisch Cancer Institute at Mount Sinai The Mount Sinai Health System has received a $7 million grant from the Multiple Myeloma Research Foundation for a three-year project that aims to fast-track novel translational concepts to improve outcomes for people with high risk myeloma, the second most common blood cancer in the United States. Read More

University of Florida Health Cancer Center Sherise Rogers, MD, has received the inaugural Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Award from Conquer Cancer, the American Society of Clinical Oncology Foundation, funded by the Bristol Myers Squibb Foundation. The award is named for AACI President Robert A. Winn, MD, director of VCU Massey Comprehensive Cancer Center. Read More

Duke Cancer Institute, Duke University Medical Center The Duke University School of Medicine Department of Head and Neck Surgery & Communication Sciences recently launched Project CHECKERS (Community Head and NEck Cancer Knowledge, Engagement, Research and Screening), a Duke Cancer Institute-funded pilot project to bring head and neck cancer resources and education to the community. Read More

Fred Hutchinson Cancer Center Five Fred Hutchinson/University of Washington/Seattle Children’s Cancer Consortium researchers have received additional funding from the Breast Cancer Research Foundation to continue ongoing studies. The physician-scientists funded for another year include Nancy E. Davidson, MD; Chris Li, MD, PhD; Anne McTiernan, MD, PhD; Nora Disis, MD; and Mary-Claire King, PhD. Read More

University of Michigan Rogel Cancer Center Daniel F. Hayes, MD, received the Brinker Award for Clinical Research from Susan G. Komen. The award recognizes physician-scientists for their work to improve breast cancer patient outcomes. Dr. Hayes has created and conducted validations studies for tumor biomarker tests, which predict prognosis, chemotherapy response, recurrence, and treatment side effects. Read More

Sylvester Comprehensive Cancer Center, University of Miami Researchers at Sylvester Comprehensive Cancer Center have found that country of birth—not just geographic region—is a key risk factor for gastric intestinal metaplasia, a precursor of stomach cancer. Read More

Vanderbilt-Ingram Cancer Center By mapping the cellular and molecular geography of colorectal cancer, Vanderbilt University and Vanderbilt University Medical Center researchers collaboratively have discovered why most colorectal tumors escape detection and destruction by the body’s immune system. Read More

Hollings Cancer Center, Medical University of South Carolina William Hawkins, MD, joined MUSC Hollings Cancer Center on January 1, in the newly created role of deputy director, where he will focus on strengthening translational research, increasing clinical trials across South Carolina. Read More

Karmanos Cancer Institute, Wayne State University Karmanos Cancer Institute welcomes Morhaf Al Achkar, MD, PhD, MSCR, FAAFP, as the associate center director for education. Dr. Al Achkar brings over 10 years of professional experience to his new role, along with valuable personal experience as a seven-year stage IV lung cancer survivor. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Baylor College of Medicine’s Culinary Stars Shine for Cancer Research event raised $6.2 million to support cancer research at Baylor's Dan L Duncan Comprehensive Cancer Center. The event featured offerings of Houston’s rich and vibrant cuisines prepared by chefs who have conquered “Top Chef” and won James Beard and Michelin awards. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute at the University of Utah has appointed Shannon Buckley, PhD, as co-leader of the Cell Response and Regulation Program. The program concentrates on cellular mechanisms of cancer biology and how healthy cells transform into cancer. Read More

University of Michigan Rogel Cancer Center With a new $3.4 million grant from the National Cancer Institute, a team of Rogel Cancer Center researchers will develop new tools to detect changes in precancerous lesions that are likely to become oral cancers. Read More

Roswell Park Comprehensive Cancer Center Replacing brentuximab vedotin with nivolumab in first-line treatment combined with the chemotherapy regimen AVD improved progression-free survival in pediatric patients with newly diagnosed, advanced-stage classic Hodgkin lymphoma, report the authors of a Phase III clinical trial sponsored by SWOG Cancer Research Network. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center More students than ever will be able to participate in meaningful cancer-focused research experiences through summer programs at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, thanks to two new five-year grants from the National Cancer Institute totaling more than $3.3 million. Read More

Cedars-Sinai Cancer Cedars-Sinai Cancer is part of an unconventional consortium dedicated to fighting cancer through the integration of diverse scientific disciplines. The effort, known as the Convergent Science Cancer Consortium, is funded through a $3.2 million grant from the U.S. Department of Defense. Read More

UCSF Helen Diller Family Comprehensive Cancer Center The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025. Dr. Small is deputy director and chief scientific officer of the UCSF Helen Diller Family Comprehensive Cancer Center. Read More

The Tisch Cancer Institute at Mount Sinai Nina Bhardwaj, MD, PhD, and Miriam Merad, MD, PhD, were inducted as fellows of the Academy of Immuno-Oncology, Society for Immunotherapy of Cancer (SITC), at the SITC Annual Meeting in November. They were honored as scientists who have launched the field of cancer immunotherapy and who are advancing the field and the next generation of immuno-oncologists. Read More

Huntsman Cancer Institute at the University of Utah Researchers at Huntsman Cancer Institute at the University of Utah discovered that the level of blood and immune cells in mouse model offspring would fluctuate based on the amount of folic acid consumed by their mothers during pregnancy. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute New evidence shows that artificial intelligence (AI) could help identify two rare blood cancers known as prefibrotic primary myelofibrosis and essential thrombocythemia. Distinguishing between these two blood cancers is difficult but critical to help guide treatment and enroll patients to clinical trials. Read More

UCLA Jonsson Comprehensive Cancer Center Aditya Bardia, MD, has joined the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center where he will assume several leadership roles including director of translational research integration and co-director of the Breast Cancer Disease Site Group for the cancer center. Read More

Hollings Cancer Center, Medical University of South Carolina Angela J. Yoon, DDS, has been appointed director of the MUSC Hollings Cancer Center Biorepository and Tissue Analysis Shared Resource, overseeing a growing collection of cancer-associated biospecimens that allow researchers to translate biological discoveries into prevention, diagnosis, and treatment of cancer. Read More

Fox Chase Cancer Center in Philadelphia seeks an accomplished breast medical oncologist and leader to serve as Chief, Breast Medical Oncology. The Organization In 2012, Fox Chase joined Temple University Health System, further expanding research and treatment expertise throughout the region. The past few years have seen significant advances in Fox Chase’s clinical, operational, research, and financial performance. With a catchment area of nearly 7.3 million people across six counties in sout…

Cedars-Sinai Cancer Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study suggests targets for therapies to protect the liver both from cancers that originate there and cancers that spread to the liver from other parts of the body. Read More

Huntsman Cancer Institute at the University of Utah Alana Welm, PhD, senior director of basic science at Huntsman Cancer Institute and professor of oncological sciences at the University of Utah, received the 2023 American Association for Cancer Research Outstanding Investigator Award for Breast Cancer Research. Read More

Montefiore Einstein Comprehensive Cancer Center New research finds patients treated with first-line immunotherapy for advanced non-small cell lung cancer showed similar results in terms of survival, progression-free survival, and treatment duration, regardless of race or ethnicity, even with differences in income and insurance. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute The National Academy of Inventors has elected Krystof Bankiewicz, MD, PhD, and Michael Tweedle, PhD (pictured), to its 2023 class of Fellows. Dr. Tweedle is a member of the Translational Therapeutics Program at OSUCCC - James. Read More

Fox Chase Cancer Center, Temple Health Edna "Eti" Cukierman, PhD, co-leader of the Cancer Signaling and Microenvironment Research Program and co-director of The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, has been appointed to the newly created Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research. Read More

The Tulane Cancer Center (TCC) of the Tulane University School of Medicine, the preeminent research university in Louisiana, seeks an Administrative Director. TCC, in collaboration with the Louisiana Cancer Research Center, its health system partner, LCMC and LSU is an emerging cancer center with the goal of seeking the first NCI designation in the state in the next 5-7 years. The Administrative Director will report to the Tulane Cancer Center Director and work closely with the TCC Director to…

Representatives Brian Fitzpatrick (R-PA), co-chair of the House Cancer Caucus, and Debbie Dingell (D-MI), have jointly introduced the Knock Out Cancer Act (KO Cancer Act) in the 118th Congress. This bipartisan legislation seeks to revolutionize cancer research funding by allocating a 25 percent increase to the National Cancer Institute's budget for the fiscal years 2024 through 2028. Pictured, left to right: Representatives Brian Fitzpatrick and Debbie Dingell Read More

UCSF Helen Diller Family Comprehensive Cancer Center In a recently published study, a UCSF research team investigated the impact of pre- and post-natal exposures to tobacco smoke on the survival rate of children with acute lymphoblastic leukemia and acute myeloid leukemia (AML). They found that paternal preconception smoking decreased 5-year survival in children with AML. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Using a liquid biopsy to study genetic material from tumors shed into the bloodstream together with immune cells could help clinicians predict which patients with advanced lung cancers are responding to immunotherapies and which patients may develop immune-related side effects, according to research by investigators at the Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy, and …

University of Florida Health Cancer Center For many in rural North Central Florida, access to mammography services is limited. But now, with a $1.5-million grant from University of Florida President Ben Sasse’s strategic funding initiative, the UF Health Cancer Center will launch an initiative called Expanding Access to Breast Cancer Screening in North Central Florida. Jonathan D. Licht, MD, is director of the center. Read More

Stanford Cancer Institute Ash Alizadeh, MD, PhD, and Maximilian Diehn, MD, PhD, are senior authors on a study finding that circulating tumor DNA can identify which Hodgkin lymphoma patients are responding well to treatment and which are likely to have a disease recurrence. It also revealed that Hodgkin lymphoma can be divided into two groups with different genetic changes and prognoses. Read More

Roswell Park Comprehensive Cancer Center A single infusion of the CAR T cell therapy ciltacabtagene autoleucel produced deep, durable responses in multiple myeloma patients whose disease had progressed less than a year after autologous stem cell transplant or who experienced relapse after receiving up to three lines of initial therapy, as seen in the latest follow-up data for two cohorts of participants in the Phase II clinical trial CARTITUDE-2. Read More

Vanderbilt-Ingram Cancer Center Vanderbilt researchers led a clinical trial combining atezolizumab, an immunotherapy, in combination with chemotherapy in patients with metastatic triple-negative breast cancer to both evaluate the efficacy of the treatment combination and to understand biomarkers of response to immunotherapy. Read More

The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act (H.R. 4189/S.2016) was initially introduced in 2016. Reintroduced in 2023, the comprehensive, bicameral, and widely supported bill aims to expand the telehealth services covered by Medicare and to maintain and bolster the progress made during the COVID-19 pandemic. Read More

Affectionately deemed “the city of bridges,” Pittsburgh is home to nearly 450 bridges, connecting the city’s diverse neighborhoods across three major rivers. Though AACI is headquartered in Pittsburgh, that is not the only reason we chose “building bridges” as the theme of the 2023 annual report. It’s also an apt summary of AACI’s work throughout the year, in which the association served as a central hub linking cancer centers with government agencies, pharmaceutical and tech companies, cancer …

AACI invites you to promote your cancer center or business by purchasing an ad in the AACI Update. Your newsletter ad may highlight a conference or a new initiative. Supporters may include links to their website and any upcoming events. Ads can be purchased monthly or in several packages. Read More

GW Cancer Center Sora Ely, MD, has joined the GW Cancer Center and the GW Medical Faculty Associates as a thoracic surgeon. She treats benign and malignant pathologies of the chest and foregut. Note: This story originally appeared in the December AACI Update with an incorrect link. Read More

The Stanford Cancer Institute (SCI) seeks a fellowship-trained specialist in medical oncology to join our Early Drug Development Program as an Assistant Professor in the University Medical Line or University Tenure Line. The successful candidate should be a fellowship-trained specialist in medical oncology, with a focus on early-phase clinical trials. Additionally, she or he should have a demonstrated track record or significant potential in obtaining research funding, along with a history of p…

UPMC Hillman Cancer Center (https://hillman.upmc.com/), a nationally and internationally renowned NCI-designated comprehensive cancer center, is seeking candidates for the Vice President, Clinical Research, who will be responsible for all aspects of the clinical research function for the Cancer Center. Reporting to the Director, this individual will work in conjunction with physician leadership as the key operational stakeholder for all research studies, standard operating procedures, regulati…

The Division of Hematology/Oncology in the Department of Medicine at the Larner College of Medicine, the University of Vermont Cancer Center and its teaching hospital, the UVM Medical Center is seeking a physician-scientist/academic clinician to serve as Associate Director of Clinical & Translational Research. The position is available at the rank of Associate Professor or Full Professor in the Clinical Scholar Pathway.  This position involves approximately 50% clinical effort with remainin…

Sr. Director, Clinical Trial Operations Please apply for this role at: https://careers-fhcrc.icims.com/jobs/26607/sr.-director%2c-clinical-trial-operations/job Overview Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington. The Senior Director, Clinical Trial Operati…

WVU Cancer Institute The WVU Cancer Institute continues to work toward National Cancer Institute designation as it begins making investments in cancer care and research utilizing the $50 million commitment from the State of West Virginia announced last summer. Two new School of Medicine departments—the Department of Hematology and Oncology and the Department of Cancer Prevention and Control—will have a unique mission and focus that leaders say will set WVU apart from peer institutions. …

Association of American Cancer Institutes AACI and the Catchment Area Research Data Science (CARDS) listserv community announce a series of webinars dedicated to discussions around cancer center data collection, analysis, and utilization. The CARDS listserv and webinars are aimed at individuals at AACI cancer centers working in community outreach, biostatistics, and cancer informatics. The first CARDS webinar, "Unveiling Insights: Using Data to Guide Catchment Area Strategy," will be hel…

Following an extensive national search, Diane M. Simeone, MD, has been appointed director of UC San Diego Moores Cancer Center, effective April 1. Dr. Simeone currently serves as the Laura and Isaac Perlmutter Professor of Surgery, director of the Pancreatic Cancer Center, and the associate director of translational research at Perlmutter Cancer Center at NYU Langone. Read More

American Cancer Society The American Cancer Society Leadership in Oncology Navigation (ACS LION) is a standardized training and credentialing program that helps patient navigators deliver essential nonclinical support to individuals, caregivers, and families facing cancer. The goal of the program is to help build a standardized professional knowledge base and positively impact oncology patients by expanding access to high-quality navigation programs and services. Standardized training wi…

American Society of Clinical Oncology A new call-to-action published in the journal Cancer details practical steps for the oncology research and clinical care communities to expand access to clinical trials and enable patients to participate closer to their homes. The paper, authored by members of an American Society of Clinical Oncology (ASCO) Task Force, illuminates the importance of enabling patients to receive trial related testing and care near their homes, rather than requiring pat…

Wilmot Cancer Institute, UR Medicine David Linehan, MD, is the new CEO of the University Rochester Medical Center (URMC), dean of the School of Medicine and Dentistry, and senior vice president for health sciences. Prior to this appointment, the surgical oncologist, internationally renowned for his clinical innovation and research into new treatments for pancreatic cancer, guided URMC’s Department of Surgery through a period of tremendous growth. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute at the University of Utah rang in the new year with new leadership roles for Theresa L. Werner, MD, and Neeraj Agarwal, MD, FASCO. Dr. Werner is the new deputy director of Huntsman Cancer Institute and Dr. Agarwal is the new senior director for clinical research. Read More

Oncologist and researcher, Edith P. Mitchell, MD, MACP, FCCP, FRCP (London), died January 21. Dr. Mitchell was slated to present a keynote at the 2024 AACI Leadership Diversity and Development Workshop. She shared her expertise at meetings of AACI's Clinical Research Innovation and Physician Clinical Leadership Initiative and as a member of the Leadership Diversity and Development Initiative Steering Committee. At the time of her death, Dr. Mitchell was the enterprise vice president for cancer …

Roswell Park Comprehensive Cancer Center is America’s first cancer center focused exclusively on cancer research, founded in 1898 by Dr. Roswell Park. His revolutionary model of a “multidisciplinary approach” to cancer — with scientists and clinicians working in concert and collaboratively — has become the standard by which all modern-day comprehensive cancer centers are measured. Roswell Park was among the first centers to receive National Cancer Institute (NCI) designation in 1974 and is the …

The University of Vermont Cancer Center and the Division of Hematology/Oncology in the Department of Medicine at the Larner College of Medicine is seeking an individual with expertise in protocol writing for appointment as a Faculty Scientist.  Candidates should hold a PhD degree or MD degree or equivalent, with at least 5 years’ experience in clinical research and development of clinical research proposals. Candidates should have documented successful experience in scientific investigations wi…

The UPMC Hillman Cancer Center, celebrating its 39th year as a leading center for cancer research, is recruiting outstanding basic science faculty who are working in the field of Translational Cancer Research at the Professor level to join established programs within the UPMC Hillman Cancer Center at the University of Pittsburgh. We are currently recruiting for an Associate Director and full-time Professor with tenure to carry out cutting-edge cancer research in the area of Translational Cance…

The UPMC Hillman Cancer Center, celebrating its 39th year as a leading center for cancer research, is recruiting outstanding basic science faculty who are working in the field of Cancer Biology, Oncology, DNA repair or Immunology at the Professor level to join the senor leadership team and drive recruitment and help oversee 7 established research programs and shared resources within the UPMC Hillman Cancer Center at the University of Pittsburgh. We are currently recruiting for an Associate Dir…

Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the diversity and excellence of our academic community. Description JOB DESCRIPTION: Designs and implements information technology solutions to support and advance the research and data needs of researchers within a specific department. Actively collaborates with investigators to identify an…

Karmanos Cancer Institute, Wayne State University Karmanos Cancer Institute has announced that it will be the first provider in the country to offer patients the new FDA-approved TheraBionic P1 device for the treatment of advanced hepatocellular carcinoma. The TheraBionic P1 emits low levels of radio-frequency electromagnetic fields that block the growth of tumor cells without affecting healthy tissue. Read More

Registration is now open for AACI's joint Hill Day with the American Association for Cancer Research (AACR), which will take place in Washington, DC, on Thursday, May 16. Your participation in Hill Day is critical to sharing our message with our legislators in Washington: that stable, predictable funds are needed to advance cancer research and care at our nation’s cancer centers. Read More

Duke Cancer Institute, Duke University Medical Center While the risks of drug use, smoking, and drinking during pregnancy are widely accepted, a new survey of parents has identified clear associations between certain types of childhood cancers and gestational substance use, notably cannabis. The study, which appears in the journal Cancer Epidemiology, Biomarkers, and Prevention, was led by Duke Cancer Institute member Kyle Walsh, PhD, associate professor in the departments of Neurosurger…

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death, according to a new meta-analysis co-directed by investigators from the Johns Hopkins Kimmel Cancer Center. Read More

UCLA Jonsson Comprehensive Cancer Center A new study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center shows that using high doses of radiation while integrating an ablative radiotherapy technique called stereotactic ablative radiotherapy concurrently with chemotherapy is safe and effective in treating people with locally advanced non-small cell lung cancer that is not suitable for surgery. Read More

Vanderbilt-Ingram Cancer Center The Society of Women in Urologic Oncology (WUO) has named Amy Luckenbaugh, MD, to chair its executive board until November 2025. She is the inaugural chair of the WUO, whose core objective is to advance the recruitment, retention, and promotion of women in urologic oncology with the goal of fostering diversity, equity, and inclusion within the Society of Urologic Oncology. Read More

Abstract submissions are now being accepted for the 16th Annual AACI CRI Meeting, June 24-26, at the Loews Chicago O'Hare Hotel in Rosemont, IL. This year’s meeting theme will focus on compassion and collaboration through clinical trials. Please visit the 2024 Call for Abstracts page for important dates, templates, and more information. Read More

Winship Cancer Institute of Emory University Results of the IDEA clinical trial suggest that omitting radiation may be safe in certain postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer. The five-year follow-up of the IDEA clinical trial, presented at the 2023 San Antonio Breast Cancer Symposium and simultaneously published in the Journal of Clinical Oncology, reveals that almost all patients who opted out of adjuvant radiotherapy after bre…

UCSF Helen Diller Family Comprehensive Cancer Center A UCSF-led clinical trial shows improved benefit of combination drug therapy without worse side effects. Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase III clinical trial has found. Read More

University of New Mexico Comprehensive Cancer Center Jennifer Gillette, PhD, has been named the UNM Comprehensive Cancer Center associate director for training and education. Dr. Gillette is a professor and senior director for research for the UNM Department of Pathology. Angela Wandinger-Ness, PhD, formerly held this role through the most recent Cancer Center Support Grant competitive renewal. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T-cell therapy for multiple myeloma, the second most common malignancy among blood cancers. Read More

Fox Chase Cancer Center, Temple Health Rebecca Shulman, MD, was recently recognized with the American Society for Radiation Oncology-Breast Cancer Research Foundation Emerging Investigator Award to Build a Diverse Scientific Workforce. Her project, "Combination Therapy with Radiotherapy, Immune Checkpoint Blockade, and Curaxin Enhances Tumor Regression in Metastatic Triple-Negative Breast Cancer," is a collaborative undertaking with Siddharth Balachandran, PhD. Read More

University of Michigan Rogel Cancer Center Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment. They also found a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect. Read More

Stanford Cancer Institute Stanford Cancer Institute member Michelle Monje, MD, PhD, is the lead author on a study finding that the maximum tolerated dose of panobinostat in children is 10 mg/m2/dose 3 times a week for 3 weeks on/3 weeks off in children with progressive DIPG/DMG and 22 mg/m2/dose administered 3 times per week for 1 week on/1 week off when administered in a similar population preprogression. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Researchers in the Eberlin Lab for Medical Mass Spectrometry at Baylor College of Medicine will receive $3 million in funding from The Marcus Foundation to further develop MasSpec Pen technology in breast cancer surgeries. The MasSpec Pen is a breakthrough device, developed by Livia Eberlin, PhD, and colleagues, for intraoperative use and surgical guidance. Read More

Siteman Cancer Center Grant Challen, PhD, a Washington University researcher at Siteman Cancer Center, has received a Leukemia & Lymphoma Society Career Development Program Scholar Achievement Award, which will provide funding for two to five years. Read More

AACI, the American Society for Transplantation and Cellular Therapy, and the Association of Community Cancer Centers, recently announced the RECUR initiative, a collaboration aimed at revolutionizing the evaluation process for CAR T therapy. Peter Riedell, MD, is the chair of AACI's CAR T Steering Committee. Read More

Ted A. James, MD, MHCM, FACS, will present the closing keynote, "Inclusive Team Building: Strategies for Cancer Center Leadership Excellence," at 1:15 pm central time on Wednesday, March 13, during the 2024 AACI Leadership Diversity and Development Workshop in Rosemont, IL. Dr. James is a surgical oncologist and cancer center medical director dedicated to transforming health care by promoting patient-centered care and fostering positive workplace culture. Read More

University of New Mexico Comprehensive Cancer Center The UNM Comprehensive Cancer Center completed the first allogeneic stem cell transplant in the state. The team also recently completed a haploidentical transplant. Such transplants make treatment possible for many New Mexican patients, who may not find matched donors in the registries of unrelated donors. Matthew Fero, MD, leads the stem cell transplantation team. Read More

City of Hope Comprehensive Cancer Center According to preclinical research, scientists have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can also attack cancer. Furthermore, these cells, called human type 2 innate lymphoid cells, can be expanded outside of the body and applied in larger numbers to overpower a tumor’s defenses and eliminate malignant cells in mouse models with cancer. Read More

The Tisch Cancer Institute at Mount Sinai Researchers have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer. And in an early parallel study in humans, combining immunotherapy with dupilumab—an Interleukin-4 (IL-4) receptor-blocking antibody widely used for treating allergies and asthma—boosted patients' immune systems, with one out of the six experiencing significant tumor reduction. Read More

Karmanos Cancer Institute, Wayne State University Karmanos Cancer Institute has appointed Doris Ranski-Zazula, RN, MSA, as the vice president of the Karmanos Cancer Network, part of McLaren Health Care. The network has 15 locations anchored by the Karmanos freestanding cancer hospital headquartered in Detroit. Read More

UK Markey Cancer Center A UK Markey Cancer Center researcher has received a $2.6 million grant from the National Cancer Institute to study LH2b, a newly discovered enzyme linked to lung cancer progression. Houfu Guo, PhD, an assistant professor in the UK College of Medicine’s Department of Molecular and Cellular Biochemistry, aims to understand how LH2b contributes to metastasis. Read More

UAMS Winthrop P. Rockefeller Cancer Institute Researchers at the University of Arkansas for Medical Sciences (UAMS) recently received two awards totaling $2.23 million for the continuing examination of therapies to treat multiple myeloma. The projects are funded by a $1.73 million National Institutes of Health (NIH) U54 grant and a $500,000 Myeloma Solutions Fund award. Baylor College of Medicine and Duke University are collaborating on the NIH grant. The Myeloma Solutions Fund award inc…

Office of Cancer Health Equity - Program Manager, Strategic Planning & Partnerships (Hybrid) The hiring entity is a part of the Stanford Cancer Institute (SCI), which is one of an elite number of National Cancer Institute-Designated Comprehensive Cancer Centers in the country, and is a prominent, dynamic, growing and complex Institute within the Stanford University School of Medicine. The Stanford Cancer Institute (SCI) was re-designated as a comprehensive cancer center by the NCI in early…

Job Description As the Assistant Director of Study Coordination at the UF Health Cancer Center, you will be responsible for leading the SC division of our Clinical Research Office and overseeing clinical trials operations for our portfolio of clinical trials. Leadership experience, expert knowledge of the clinical research process, and expertise in coordinating clinical research is necessary for success in this role. Job Responsibilities Oversight of the Division including management of pers…

Job Description: This role serves as a centralized project manager for strategic projects and initiatives stemming from the aims and objectives of the Cancer Center Support Grant and Center-wide strategic plan. Experience with high-level project management and direct responsibility for complex, multi-phase projects is necessary for success in this role. Job Duties: High-level coordination of strategic initiatives and projects set by the Associate Director for Administration on behalf of the …

Job Description You will be responsible for leading the PMNO division of our Clinical Research Office and overseeing the operations of our IIT project management team, data management unit, and Affiliate Research Consortium (ARC). Leadership experience, expert knowledge of the clinical research process, and expertise in coordinating clinical research is necessary for success in this role. Job Responsibilities Oversight of the Division including management of personnel, financial, and operati…

Scientific Director, Multiple Myeloma Program Fred Hutchinson Cancer Center: Translational Science and Therapeutics Division Location: Seattle, WA Please apply for this role at: https://apply.interfolio.com/138954 Description The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) are jointly recruiting a full-time physician-scientist at the Associate Professor or Full Professor level without tenure due to funding (WOT) to serve as Scientific Director of the multi…

University of Florida Health Cancer Center In the latest development in precision medicine approaches to treating pediatric leukemia, UF Health researchers have developed a genetic score to predict patient outcomes with a promising targeted drug treatment. Read More

Hollings Cancer Center, Medical University of South Carolina Shikhar Mehrotra, PhD, will take on the role of co-leader of the cancer biology and immunology research program at MUSC Hollings Cancer Center alongside Philip Howe, PhD. As co-leader, Dr. Mehrotra anticipates seeing more collaborative projects that take a holistic view of the mechanisms of cancer growth. Read More

Siteman Cancer Center Four Washington University physician-scientists at Siteman Cancer Center, including Todd A. Fehniger, MD, PhD, have received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance. The funding will support a Phase I clinical trial of a novel cell-based immunotherapy developed at Washington University against melanoma. Read More

Memorial Sloan Kettering Cancer Center, headquartered in Manhattan, seeks a dynamic, progressive, and innovative human resources executive to serve as its next Chief People Officer (CPO). This is an exciting opportunity with one of the world's most respected healthcare organizations devoted exclusively to cancer and recognized as one of the top two cancer hospitals in the country by U.S. News & World Report. The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular…